Affinity Asset Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $6.4M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $2.52M | Sell |
|
|||||
|
2023
Q3 | $4.34M | Sell |
|
|||||
|
2023
Q2 | $5.16M | Buy |
|
|||||
|
2023
Q1 | $4.29M | Sell |
|
|||||
|
2022
Q4 | $8.67M | Sell |
|
|||||
|
2022
Q3 | $10.3M | Sell |
|
|||||
|
2022
Q2 | $11.6M | Buy |
|
|||||
|
2022
Q1 | $14.1M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $5.72M | Buy |
|
|||||
|
2021
Q2 | $2.63M | Hold |
|
|||||
|
2021
Q1 | $2.58M | Buy |
|
|||||
|
2020
Q4 | $1.67M | Buy |
|